Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Regulatory News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,240.00
Bid: 1,240.00
Ask: 1,245.00
Change: -37.00 (-2.90%)
Spread: 5.00 (0.403%)
Open: 1,277.00
High: 1,284.00
Low: 1,240.00
Prev. Close: 1,277.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

30 Dec 2022 12:29

RNS Number : 3787L
Indivior PLC
30 December 2022
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BN4HT335

Issuer Name

INDIVIOR PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights; An acquisition or disposal of financial instruments

3. Details of person subject to the notification obligation

Name

JPMorgan Chase & Co.

City of registered office (if applicable)

 

Country of registered office (if applicable)

US

4. Details of the shareholder

Name

City of registered office

Country of registered office

J.P. Morgan Securities plc

5. Date on which the threshold was crossed or reached

13-Oct-2022

6. Date on which Issuer notified

29-Dec-2022

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

2.977330

4.370361

7.347691

10109449

Position of previous notification (if applicable)

3.418593

3.951037

7.369630

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BN4HT335

4096412

2.977330

Sub Total 8.A

4096412

2.977330%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Depository Receipt

n/a

n/a

5

0.000004

Sub Total 8.B1

5

0.000004%

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Cash-settled Equity Swap

24/10/2022

24/10/2022

Cash

145400

0.105679

Cash-settled Equity Swap

28/10/2022

28/10/2022

Cash

307505

0.223499

Cash-settled Equity Swap

07/02/2023

07/02/2023

Cash

1194152

0.867926

Cash-settled Equity Swap

15/02/2023

15/02/2023

Cash

594746

0.432270

Cash-settled Equity Swap

01/03/2023

01/03/2023

Cash

2173

0.001579

Cash-settled Equity Swap

08/03/2023

08/03/2023

Cash

555791

0.403957

Cash-settled Equity Swap

17/03/2023

17/03/2023

Cash

1282764

0.932331

Cash-settled Equity Swap

17/05/2023

17/05/2023

Cash

1266950

0.920837

Cash-settled Equity Swap

30/05/2023

30/05/2023

Cash

128182

0.093164

Cash-settled Equity Swap

02/06/2023

02/06/2023

Cash

6517

0.004737

Cash-settled Equity Swap

19/07/2023

19/07/2023

Cash

8990

0.006534

Cash-settled Equity Swap

22/09/2023

22/09/2023

Cash

4600

0.003343

Cash-settled Equity Swap

27/09/2023

27/09/2023

Cash

1559

0.001133

Cash-settled Equity Swap

13/10/2023

13/10/2023

Cash

1272

0.000925

Cash-settled Equity Swap

14/11/2023

14/11/2023

Cash

12363

0.008986

Cash-settled Equity Swap

04/12/2023

04/12/2023

Cash

26597

0.019331

Cash-settled Equity Swap

05/05/2027

05/05/2027

Cash

327072

0.237721

Cash-settled Equity Swap

02/06/2027

02/06/2027

Cash

146399

0.106405

Sub Total 8.B2

6013032

4.370357%

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

JPMorgan Chase & Co.

J.P. Morgan Securities plc

4.370356

7.298802%

JPMorgan Chase & Co.

JPMorgan Chase Bank, National Association

JPMorgan Chase & Co.

J.P. Morgan SE

JPMorgan Chase & Co.

J.P. Morgan Securities LLC

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

Chain of controlled undertakings:JPMorgan Chase & Co.JPMorgan Chase Bank, National Association (100%)J.P. Morgan International Finance Limited (100%)J.P. Morgan Capital Holdings Limited (100%)J.P. Morgan Securities plc (100%)JPMorgan Chase & Co.JPMorgan Chase Bank, National Association (100%)JPMorgan Chase & Co.JPMorgan Chase Bank, National Association (100%)J.P. Morgan International Finance Limited (100%)J.P. Morgan SE (100%)JPMorgan Chase & Co.JPMorgan Chase Holdings LLC (100%)J.P. Morgan Broker-Dealer Holdings Inc. (100%)J.P. Morgan Securities LLC (100%)

12. Date of Completion

29-Dec-2022

13. Place Of Completion

London

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLFDMFESEESEEE
Date   Source Headline
31st Jul 20187:00 amRNSIndivior Preliminary Injunction Upheld
30th Jul 20187:01 amRNSDRL's Appeal of Indivior's PI Granted-in-Part
30th Jul 20187:00 amRNSUS FDA Approves Indivor's PERSERIS(TM)
27th Jul 20188:40 amRNSHolding(s) in Company
26th Jul 20189:01 amRNSHolding(s) in Company
25th Jul 20187:00 amRNSHalf-year Report
24th Jul 20187:00 amRNSHolding(s) in Company
16th Jul 20187:00 amRNSUS Court Grants Indivior Preliminary Injunction
13th Jul 20184:39 pmRNSHolding(s) in Company
12th Jul 20185:16 pmRNSHolding(s) in Company
11th Jul 20187:00 amRNSIndivior Sees FY18 Guidance Below Expectations
10th Jul 20187:00 amRNSNotice of Results
3rd Jul 20187:01 amRNSHolding(s) in Company
3rd Jul 20187:00 amRNSHolding(s) in Company
29th Jun 20187:00 amRNSIndivior's Temporary Restraining Order is Extended
21st Jun 20182:56 pmRNSHolding(s) in Company
20th Jun 20187:00 amRNSHolding(s) in Company
18th Jun 20187:00 amRNSIndivior Is Granted Temporary Restraining Order
15th Jun 20183:56 pmRNSHolding(s) in Company
15th Jun 20181:59 pmRNSIndivior Responds to Generic SUBOXONE ® Approvals
7th Jun 20189:30 amRNSHolding(s) in Company
1st Jun 20187:00 amRNSTotal Voting Rights
31st May 20187:00 amRNSCalifornia Department of Insurance subpoena
25th May 20182:25 pmRNSSUBLOCADE(TM) Submitted in Australia for Approval
24th May 20187:00 amRNSIndivior Participating in Jefferies NYC Conference
16th May 20185:50 pmRNSResult of AGM
14th May 20187:00 amRNSIndivior settlement with Par Pharmaceutical
10th May 201811:40 amRNSBlock listing Interim Review
4th May 20182:13 pmRNSDirector/PDMR Shareholding
2nd May 20187:00 amRNS1st Quarter Results
20th Apr 20187:00 amRNSIndivior's SUBLOCADE NDS Accepted by Health Canada
12th Apr 20183:56 pmRNSHolding(s) in Company
11th Apr 20184:02 pmRNSDirector Declaration
11th Apr 20187:00 amRNSNotice of Results
6th Apr 20189:31 amRNSHolding(s) in Company
5th Apr 20187:00 amRNSIndivior Asserts New SUBOXONE(R) Film Patent
4th Apr 20189:28 amRNSDirector/PDMR Shareholding
3rd Apr 20189:33 amRNSHolding(s) in Company
3rd Apr 20187:00 amRNSTotal Voting Rights
29th Mar 20187:00 amRNSIndivior and C4X Enter Licensing Agreement
27th Mar 20184:13 pmRNSHolding(s) in Company
23rd Mar 20187:00 amRNSIndivior Responds to Court Ruling ANDA litigation
22nd Mar 20181:39 pmRNSAnnual Financial Report
13th Mar 20183:14 pmRNSDirector/PDMR Shareholding
12th Mar 20184:30 pmRNSDirector/PDMR Shareholding
2nd Mar 20182:51 pmRNSHolding(s) in Company
2nd Mar 201810:24 amRNSHolding(s) in Company
1st Mar 20181:00 pmRNSIndivior Announces SUBLOCADET Available in US
1st Mar 20187:00 amRNSTotal Voting Rights
28th Feb 20185:45 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.